Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC-Reference-Cited by-同舟云学术

Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC

Published:2020-04 Issue: Volume:148 Page:102906
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Baraibar Iosune^ORCID,Mezquita Laura,Gil-Bazo Ignacio,Planchard David

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference105 articles.

1. Crystal structure of an Hsp90-nucleotide-P23/Sba1 closed chaperone complex;Ali;Nature,2006

2. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas;Arcila;Clin. Cancer Res.,2012

3. EGFR Exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics;Arcila;Mol. Cancer Ther.,2013

4. LBA39_PR Neratinib with or without temsirolimus in patients with non-small cell lung cancer carrying HER2 somatic mutations: an international randomized phase II study;Besse;Ann. Oncol.,2014

5. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience;Cancer Research and Treatment;2024-07-15

2. Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters;Scientific Reports;2024-06-06

3. Small molecule anticancer drugs approved during 2021–2022: Synthesis and clinical applications;European Journal of Medicinal Chemistry;2024-06

4. Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment;Heliyon;2024-06

5. Targeted Therapies for EGFR Exon 20 Insertion Mutation in Non-Small-Cell Lung Cancer;International Journal of Molecular Sciences;2024-05-29